Filing Flows

Filing Flows › Vistagen Therapeutics (VTGN) › Who owns the stock

Who owns Vistagen Therapeutics (VTGN) stock

49 funds reported Vistagen Therapeutics (VTGN) shares in their latest 13F filings, worth $3.9M in all. The largest holder is Vanguard Group ($1.2M). Last quarter 22 funds added to their stakes and 29 cut them.

Largest holders of VTGN (13F)Largest holders of VTGN (13F)Vanguard Group$1.2MCommodore Capital LP$630KVanguard Capital Management LLC$356KTwo Sigma Investments, LP$192KAcadian Asset Management LLC$178KRenaissance Technologies LLC$165KCubist Systematic Strategies, LLC$156KIkarian Capital, LLC$117KAdvisorShares Investments LLC$99KLuminus Management LLC$91K

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Group1,824,738$1.2Mincrease2025-12-31
Commodore Capital LP2,788,620$630Knew2026-06-30
Vanguard Capital Management LLC1,574,200$356Kunchanged2026-06-30
Two Sigma Investments, LP847,992$192Kincrease2026-06-30
Acadian Asset Management LLC794,579$178Kincrease2026-06-30
Renaissance Technologies LLC730,500$165Kincrease2026-06-30
Cubist Systematic Strategies, LLC43,953$156Knew2025-09-30
Ikarian Capital, LLC519,077$117Kunchanged2026-06-30
AdvisorShares Investments LLC438,643$99Kincrease2026-06-30
Luminus Management LLC403,115$91Kincrease2026-06-30
Geode Capital Management, LLC365,002$83Kdecrease2026-06-30
ADAR1 Capital Management, LLC351,141$79Kdecrease2026-06-30
BlackRock345,432$78Kdecrease2026-06-30
Group One Trading LLC304,385$69Kincrease2026-06-30
Verdad Advisers, LP293,343$66Kincrease2026-06-30

Vistagen Therapeutics' latest quarter

Vistagen Therapeutics, Q1 FY27: revenue $1.5M (+505% year over year), operating margin -904.3%, net loss $13.0M, operating cash flow −$14.7M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most VTGN stock?

By the latest 13F filings: Vanguard Group ($1.2M); Commodore Capital LP ($630K); Vanguard Capital Management LLC ($356K); Two Sigma Investments, LP ($192K); Acadian Asset Management LLC ($178K).

What is the short interest in VTGN?

2,472,435 shares were sold short at the 2026-10-15 settlement, -34.08% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.